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Background:  Angiogenesis is a compensatory response to chronic tissue hypoxia in patients with atherosclerosis. Since this response is 
inadequate in many patients, novel cell-based therapies that promote angiogenesis are being developed. The mechanisms by which regenerative 
cells restore perfusion remain controversial. We hypothesized that bone marrow derived human mesenchymal stem cells (MSCs) promote vascular 
network formation by enhancing the tissue responsiveness to hypoxia.
Methods:  In vitro angiogenesis assays were performed by plating human aortic endothelial cells (HAECs) on growth factor reduced Matrigel. To test 
the effect of MSC supplementation on HAEC network formation, MSCs were added to Matrigel prior to gel polymerization. Analyses of in vitro MSC/
HAEC interactions were performed with confocal microscopy. Collagen/fibronectin gels seeded with either HAECs or HAEC+MSC combinations were 
subcutaneously implanted into NOD/SCID mice for 1 week and plug explants were evaluated by quantitative PCR and immunofluorescence.
Results:  MSCs increased the total HAEC tube length from 17820±1576 to 25310±994 (p<0.01). In vivo, only HAEC+MSC combo plugs resulted 
in the formation of functional blood vessels containing red blood cells. Compared to HAEC plugs, the HAEC+MSC combo plugs also showed relative 
increases in the expression of VEGF (7.7 ± 0.9, p<0.005) and the proliferation regulator cyclin D1 (4.1 ± 0.7, p<0.05). Importantly, assessment of 
hypoxia responsiveness revealed marked expression increases of the hypoxia regulator HIF-1_ (1.9 ± 0.1, p<0.05) and the glucose transporter 
Glut1 (4.3 ± 0.7, p<0.005) in HAEC+MSC combo plugs.
Conclusions:  The addition of adult MSCs to HAECs markedly enhances blood vessel formation. A striking finding is the activation of the HIF-1_ 
pathway as evidenced by increased downstream expression of Glut1 and the angiogenic growth factor VEGF when MSCs are present. This suggests 
that MSC addition may sensitize implanted grafts to hypoxia, allowing for cell survival, interaction, and proliferation. These data point to HIF-1_ 
activation as a novel mechanism by which MSC supplementation can enhance angiogenesis in an ischemic microenvironment.
